{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:45:11Z","timestamp":1791189911518,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1093\/eurheartj\/ehs132","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T20:44:13Z","timestamp":1340052253000},"page":"2946-2954","source":"Crossref","is-referenced-by-count":34,"title":["Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality"],"prefix":"10.1093","volume":"33","author":[{"given":"Lars","family":"Lind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassome","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Kotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Machecourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Ninio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Tedgui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ahlstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad","family":"Mallat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,6,17]]},"reference":[{"key":"key\n\t\t\t\t20170515131024_EHS132C1","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/CIRCULATIONAHA.110.936393","article-title":"Lipoprotein-associated and secreted phospholipases A in cardiovascular disease: roles as biological effectors and biomarkers","volume":"122","author":"Mallat","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131024_EHS132C2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.biochi.2010.02.002","article-title":"Extracellular phospholipases in atherosclerosis","volume":"92","author":"Karabina","year":"2010","journal-title":"Biochimie"},{"key":"key\n\t\t\t\t20170515131024_EHS132C3","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis","volume":"26","author":"Kolodgie","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C4","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/eurheartj\/ehp309","article-title":"Expression of lipoprotein-associated phospholipase A(2) in carotid artery plaques predicts long-term cardiac outcome","volume":"30","author":"Herrmann","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515131024_EHS132C5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0021-9150(95)05604-1","article-title":"Secretory group II phospholipase A2 in human atherosclerotic plaques","volume":"118","author":"Menschikowski","year":"1995","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515131024_EHS132C6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0021-9150(96)05946-1","article-title":"Expression of secretory group II phospholipase A2 by CD1a positive cells-in human atherosclerotic plaques","volume":"127","author":"Bobryshev","year":"1996","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515131024_EHS132C7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2006.08.062","article-title":"Expression of secretory phospholipase A2s in human atherosclerosis development","volume":"196","author":"Kimura-Matsumoto","year":"2008","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515131024_EHS132C8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.ATV.19.5.1284","article-title":"Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2","volume":"19","author":"Ivandic","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.ATV.0000051701.90972.E5","article-title":"Macrophage-expressed group IIA secretory phospholipase A2 increases atherosclerotic lesion formation in LDL receptor-deficient mice","volume":"23","author":"Webb","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1194\/jlr.M400253-JLR200","article-title":"Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition","volume":"46","author":"Ghesquiere","year":"2005","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20170515131024_EHS132C11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1161\/01.ATV.0000257133.60884.44","article-title":"Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice","volume":"27","author":"Bostrom","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C12","doi-asserted-by":"crossref","first-page":"33483","DOI":"10.1074\/jbc.M804628200","article-title":"Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis","volume":"283","author":"Sato","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515131024_EHS132C13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","article-title":"Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development","volume":"14","author":"Wilensky","year":"2008","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170515131024_EHS132C14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/FJC.0b013e318195bfbc","article-title":"Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE-\/- Mice","volume":"53","author":"Fraser","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C15","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1161\/01.ATV.0000184769.22061.da","article-title":"A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study","volume":"25","author":"Lind","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515131024_EHS132C17","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atherosclerosis.2009.10.016","article-title":"Ultrasound-assessed plaque occurrence in the carotid and femoral arteries are independent predictors of cardiovascular events in middle-aged men during 10 years of follow-up","volume":"209","author":"Davidsson","year":"2010","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20170515131024_EHS132C18","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s00330-008-0864-6","article-title":"A total atherosclerotic score for whole-body MRA and its relation to traditional cardiovascular risk factors","volume":"18","author":"Hansen","year":"2008","journal-title":"Eur Radiol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C19","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1093\/eurheartj\/ehp302","article-title":"Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease","volume":"30","author":"Koenig","year":"2009","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515131024_EHS132C20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tcm.2007.03.001","article-title":"Regulatory T cell immunity in atherosclerosis","volume":"17","author":"Mallat","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"key\n\t\t\t\t20170515131024_EHS132C21","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515131024_EHS132C22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.biochem.76.062405.154007","article-title":"Biochemistry and physiology of mammalian secreted phospholipases A2","volume":"77","author":"Lambeau","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"key\n\t\t\t\t20170515131024_EHS132C23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2005.06.056","article-title":"Circulating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromes","volume":"46","author":"Mallat","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C24","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jacc.2010.04.048","article-title":"Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events","volume":"56","author":"Tsimikas","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(09)60403-7","article-title":"Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial","volume":"373","author":"Rosenson","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515131024_EHS132C26","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque","volume":"118","author":"Serruys","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131024_EHS132C27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MOL.0b013e32833eb581","article-title":"Phospholipase A2 inhibition and atherosclerotic vascular disease: prospects for targeting secretory and lipoprotein-associated phospholipase A2 enzymes","volume":"21","author":"Rosenson","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t20170515131024_EHS132C28","first-page":"524","article-title":"The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics","volume":"100","author":"Cambou","year":"2007","journal-title":"Arch Mal Coeur Vaiss"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/33\/23\/2946\/17050416\/ehs132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:01:30Z","timestamp":1503446490000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehs132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,17]]},"references-count":28,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2012,6,17]]},"published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehs132","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,17]]}}}